Current management issues of childhood and adult immune thrombocytopenic purpura (ITP)

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 87, Issue 424, 1998, Pages 75-81

  Kuhne T ^a   Elinder, G ^b   Blanchette, V S ^c   Garvey, B ^d  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Adult; Blood platelets; Child; Immune thrombocytopenic purpura

Indexed keywords

ALPHA INTERFERON; ASCORBIC ACID; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DAPSONE; DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY; STAPHYLOCOCCUS PROTEIN A; VINCA ALKALOID; GLUCOCORTICOID;

ADULT; ADULT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; HEMATOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOADSORPTION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE TRANSFUSION; ACUTE DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; REVIEW;

ACUTE DISEASE; ADULT; CHILD; CHRONIC DISEASE; CLINICAL TRIALS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLATELET TRANSFUSION; PRACTICE GUIDELINES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 0031665227     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb01240.x     Document Type: Article

References (74)

1. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966; 68: 971-9
2. Robb LG, Tiedeman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child 1990; 65: 502-6
3. Tate RC, Evan DIK. Late spontaneous recovery of chronic thrombocytopenia. Arch Dis Child 1993; 68: 680-1
4. Cortelazzo S, Finazzi G, Guelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77: 31-3
5. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40
6. Lichtin A. The ITP practice guideline: what, why, and for whom? (Editorial). Blood 1996; 88: 1-2
7. Buchanan GR, Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 1984; 6: 355-61
8. McWilliams NB, Maurer HM. Acute idiopathic thrombocytopenic purpura in children. Am J Hematol 1979; 7: 87-96
9. Mazzucconi MG, Francesconi M, Fidani P, Nucci GD, Gandolfo GM, Afeltra A, et al. Treatment of idiopathic thrombocytopenic purpura: results of a multicentric protocol. Haematologia 1985; 70: 329-36
10. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 1984; 6: 165-8
11. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, De Veber B, Gent M. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therpy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993; 123: 989-95
12. Blanchette V, Imbach P, Andrew M, McMillan J, Wang E, Milner R, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703-7
13. Özsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989; 42: 431-5
14. Del Principe D, Menichelli A, Mon PG, De Mattia D, Mancuso G, Carnelli V, et al. Phase II trial of methylprednisolone pulse therapy in childhood chronic thrombocytopenia. Acta Haematol 1987; 77: 226-30
15. van Hoff J, Ritchey AK. Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. J Pediatr 1988; 113: 563-6
16. Albayrak D, Islek I, Kalaycí AG, Gürses N. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 1994; 125: 1004-7
17. Khalifa AS, Tolba KA, ElAlfy MS, Gadallah M, Ibrahim FH. Idiopathic thrombocytopenic purpura in Egyptian children. Acta Haematol 1993; 90: 125-9
18. Özsoylu S, Sayli TR, Özturk G. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1993; 10: 317-21
19. Imbach P, Wagner HP, Berchtold W, Gaedicke G, Hirt A, Joller P, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; 2: 464-8
20. Bussel JB, Fitzgerald-Pederson J, Feldman C. Alternation of two doses of intravenous gammaglobulin in the maintenenance treatment of patients with immune thrombocytopenic purpura: more is not always better. Am J Hematol 1990; 33: 184-8
21. Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley D. Safety and efficacy of low-dose intravenous immune globuline IVIg treatment in infants and children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1997; 19: 197-201
22. Becker T, Küenzlen E, Salama A, Mertens R, Kiefel V, Weib H, et al. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D). Eur J Pediatr 1986; 145: 166-9
23. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992; 120: 522-7
24. Gaedicke G. Childhood autoimmune thrombocytopenia: to treat or not to treat. In: Sutor AH, Thomas KB, editors. Thrombocytopenia in childhood. Stuttgart: Schattauer, 1994: 129-39
25. Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr Clin North Am 1996; 43: 757-72
26. Crosby WH. Wet purpura, dry purpura. JAMA 1975; 232: 744-5
27. Woerner SJ, Abildgaard CF, French BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981; 67: 453-60
28. Lilleyman JS. Intracranial haemorrhage in didopathic thrombocytopenic purpura. Arch Dis Child 1994; 71: 251-3
29. Blanchette VS, Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr 1985; 108: 326-7
30. McWilliams NB, Maurer HM. Acute idiopathic thrombocytopenic pupura in children. Am J Hematol 1979; 7: 87-96
31. Preiss J, Gamn H, Schniepp I, Fischer J. Anstieg der Thrombozyten bei idopathsicher thrombozytopenischer Purpura (ITP) durch eine induzierte passagere funktionelle Asplenie. Blut 1980; 41: 322
32. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997; 89: 2689-700
33. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann Intern Med 1994; 121: 259-62
34. K̈hne T, Spitz C, Imbach P. Is aseptic meningitis a sign of efficacy or an adverse effect of intravenous immunoglobulin therapy in severe immune thrombocytopenic purpura? (Abstract). Blood 1996; 88: 60b
35. Hedman A, Henter J-E, Hedlund I, Elinder G. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatrica 1997; 86: 226-7
36. Bussel JB, Pham LC, Aledort L, Nachman R. Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72: 121-7
37. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994; 330: 1560-4
38. Kühne T, Imbach P, Blanchette VS. Immune thrombocytopenic purpura: intravenous immunoglobulin versus dexamethasone versus anti-D. In: Kazatchkine MD, Morell A, editors. Intravenous immunoglobulin research and therapy. London: Parthenon, 1996: 129-34
39. Kühne T, Freedman J, Semple JW, Doyle J, Butchart S, Blanchette VS. Platelet and immune responses to oral cyclic dexamelhasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997; 130: 17-24
40. Curtis GM, Movitz D. The surgical significance of the accessory spleen. Ann Surg 1946; 123: 276-98
41. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309-17
42. Quiquandon I, Fenaux P, Caulier MT, Pagniez D, Huart JJ, Bauters F. Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Brit J Haematol 1990; 74: 223-8
43. Verlin M, Laros RK, Penner JA. Treatment of refractory thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1976; 1: 97-104
44. Reiner A, Gernsheimer T, Slichter SJ. Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 1995; 85: 351-8
45. Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM. The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med 1978; 298: 1101-7
46. Jackson CW, Edwards CC. Evidence that stimulation of megakaryocytopoiesis by low-dose vincristine results from an effect on platelets. Br J Haematol 1977; 36: 97-105
47. Harrington WJ, Ahn YS, Gilibarti JJ. Vincristine therapy of idiopathic thrombocytopenia. Clin Res 1972; 20: 787
48. Ahn YS, Harrington WJ, Seelman RC, Eytel CS. Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 1974; 291: 376-80
49. Figueroa M, Gehlsen J, Hammond D, Ondreyco S, Piro L, Pomeroy T, et al. Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med 1993; 328: 1226-9
50. Ahn YS, Rocha R, Mylvaganam R, Garcia R, Duncan R, Harrington WJ. Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women. Ann Intern Med 1989; 111: 723-9
51. McVerry BA, Auger M, Bellingham AJ. The use of danazol in the mangement of chronic immune thrombocytopenic purpura. Brit J Haematol 1985; 61: 145-8
52. Flores A, Carles J, Junca J, Abella E. Danazol therapy in chronic immune thrombocytopenic purpura. Eur J Haematol 1990; 45: 109-10
53. Schreiber AD, Chien P, Tomaski A, Cines DB. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med 1987; 316: 503-8
54. Proctor SJ, Jackson G, Carey P, Stark A, Finney R, Saunders P, et al. Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood 1989; 74: 1894-7
55. Bellucci S, Bordessoule D, Coiffier B, Tabah I. Interferon alpha-2b therapy in adult chronic thrombocytopenic purpura (ITP). Br J Haematol 1989; 73: 578-9
56. Iannaccaro P, Molica S, Santoro R. Recombinant alpha-2b interferon in refractory idiopathic immune thrombocytopenia. Eur J Haematol 1992; 48: 271
57. Dubbeld P, Hillen HFP, Scheuten HC. Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP). Eur J Haematol 1994; 52: 233-5
58. Emilia G, Messora C, Longo G, Bertesi M. Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol 1996; 93: 341-4
59. Marder VJ, Nusbacher J, Anderson FW. One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 1981; 21: 291-8
60. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thombocytopenia. N Engl J Med 1988; 319: 1374-8
61. Snyder BW Jr, Cochran SK, Balint JP Jr, Bertram JH, Mittelman A, Guthrie TH, Jones FR. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 1992; 79: 2237-45
62. Brox AG, Howson-Jan K, Fauser AA. Treatment of idiopathic thrombocytopenic purpura with ascorbate. Br J Hamatol 1988; 70: 341-4
63. Verhoef GEG, Boonen S, Boogaerts MA. Ascorbate for the treatment of refractory idiopathic thrombocytopenic purpura. Br J Haematol 1990; 74: 234-5
64. Godeau B, Bierling P. Treatment of chronic autoimmune thrombocytopenic purpura with ascorbate. Br J Haematol 1990; 75: 289-90
65. Van der Beek-Boter JW, van Oers MJH, von dem Borne AEGKr, Klaassen RJL. Ascorbate for the treatment of ITP. Eur J Haematol 1992;48:61-2
66. Novitzky N, Wood L, Jacobs P. Treatment of refractory immune thrombocytopenic purpura with ascorbate. South African Med J 1992;81:44-5
67. Jubelirer SJ. Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura. Am J Hematol 1993; 43: 44-6
68. Strother SV, Zukerman KS, LoBuglio AF. Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med 1984; 144: 2198-200
69. Jim RTS. Therapeutic use of colchicine in thrombocytopenia. Hawaii Med J 1986; 45: 221-6
70. Durand JM, Lefevre P, Hovette P, Mongin M; Soubeyrand J. Dapsone for idiopathic autoimmune thrombocytopenic purpura in elderly patients. Br J Haematol 1991; 78: 459-60
71. Godeau B, Oksenhendler E, Bierling P. Dapsone for autoimmune thrombocytopenic purpura. Am J Hematol 1993; 44: 70-72
72. Hernandez F, Linares M, Colomina P, Pastor E, Cervero A, Perez A, Perella M. Dapsone for refractory chronic idiopathic thrombocytopneic purpura. Br J Haematol 1995; 90: 473-5
73. Imbach P, Blanchette VS, Nugent D, Kühne T. Immune thrombocytopenic purpura: immediate and long-term effects of intravenous immunoglobulin. In: Kazatchkine MD, Morell A, editors. Intravenous immunoglobulin research and therapy. London: Parthenon, 1996: 135-41
74. Kühne T, Egli D, Imbach P. Epidemiology of childhood immune thrombocytopenic purpura (ITP) in a defined area in Europe and rationale and profile of an intercontinental childhood ITP registry (Abstract). Blood 1997; 90: 85b